Singh, H
Moyes, J S E
Huls, M H
Cooper, L J N
Article History
Received: 17 October 2014
Accepted: 20 October 2014
First Online: 16 January 2015
Competing interests
: Dr Cooper founded and owns InCellerate. He has patents with Sangamo BioSciences with artificial nucleases. He consults with Targazyme (formerly American Stem Cells), GE Healthcare, Ferring Pharmaceuticals, Fate Therapeutics, Janssen Pharmaceuticals and Bristol-Myers Squibb. He is on the Scientific Advisory Board of Cellectis. He receives honoraria from Miltenyi Biotec.